RRBP1 is markedly upregulated in both early-stage and late-stage cisplatin-resistant OSCC cell lines, as well as in tumor tissues from chemotherapy-non-responsive patients vs. those with chemotherapy-sensitive disease (62). This evidence concerns the gene RRBP1 and neoplasm.